ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1887

Deficiency in Micronutrients Is a Frequent Burden in Patients with Systemic Sclerosis

Jasmin Laeubli1, Rucsandra Dobrota1, Britta Maurer1, Suzana Jordan2, Benjamin Misselwitz3, Mark Fox3 and Oliver Distler1, 1Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Division of Gastroenterology, University Hospital Zurich, Zurich, Switzerland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: nutrition, Scleroderma, systemic sclerosis and vitamins

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Micronutrients are essential dietary factors involved in many metabolic processes, including oxidative stress, collagen synthesis and wound healing, which are key aspects of the pathogenesis of systemic sclerosis (SSc). Considering the frequent gastrointestinal involvement and impaired nutritional status (1,2), we hypothesized that the micronutrients could be profoundly affected in SSc patients.

Methods:  Patients with SSc were prospectively included between 2009 and 2014. Clinical assessment, data recording and quality controls were done according to EUSTAR standards. In addition, the UCLA SCTC-GIT 2.0 questionnaire was applied. The following micronutrients were measured: zinc, selenium, prealbumin, holotranscobalamin, folic acid. Patients with a specific micronutrient deficiency or with deficiency in at least one micronutrient (“any deficiency”) were compared to patients with a normal micronutrient pattern. The two-sided Fisher’s exact test, the t-test and the Mann-Whitney were used, as appropriate. Multivariable logistic regression was applied to identify predictors of a deficiency in micronutrients in SSc patients.

Results: Nearly half (43.7%) of the 176 SSc patients included had a deficiency in at least one of the measured micronutrients. The most frequent deficit was in selenium (21.9%), followed by folic acid (16.6%) and prealbumin (15.0%). Even more, 19.3% of patients had multiple micronutrient deficiencies. There was a significant association between low levels of selenium and zinc, prealbumin and zinc and folic acid and zinc. Patients with a lower body mass index (BMI) had lower zinc levels, and those with low prealbumin had more stomach symptoms. The strongest (p<0.01) clinical parameters associated with any deficiency in micronutrients were lower hemoglobin (p<0.001), higher modified Rodnan skin score (p=0.007) and proximal skin thickening (p=0.009), as shown in Table 1. Proximal skin thickening, low hemoglobin and a low BMI were confirmed in the multivariable model as independent predictors of a deficit in micronutrients in patients with SSc.

Conclusion: Our study reveals that micronutrient deficiencies are a frequent burden in SSc patients and correlate with clinical aspects of the disease. Moreover, often more than one micronutrient is affected. In our cohort, patients with proximal skin fibrosis and lower BMI were more likely to show a deficiency in micronutrients, suggesting that screening for micronutrient status should be prioritized in these patients.

References:

  1. Cereda E, et al. Disease-related nutritional risk and mortality in systemic sclerosis. Clin Nutr. 2014 Jun;33(3):558-61.
  2. Krause L, et al. Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis. 2010 Nov;69(11):1951-7.

Table 1. Correlations between disease characteristics and any micronutrient deficiency

Disease characteristics (frequencies)

% of patients with disease characteristic present when there is any micronutrient deficiency

% of patients with disease characteristic present when micronutrients are normal

Fisher’s exact test, two-sided p value

Skin thickening of the fingers of both hands extending proximal to the MCP joints

61% (36/59)

37.6% (29/77)

p = 0.009

Pitting scars on fingertips

47.4% (27/57)

29.8% (23/77)

p = 0.047

ACR-criteria for systemic sclerosis fulfilled

78.2% (61/78)

60% (57/95)

p = 0.014

CK-elevation

6.5% (5/77)

19.8% (19/96)

p = 0.014

Disease characteristics

(mean +/- SD)

Patients with any deficiency

patients with no deficiencies

Double t -test

 

BMI

23.5 +/- 4.1

24.77 +/- 4

p = 0.048

Disease characteristics (median(quartile1,3))

Patients with any deficiency

patients with no deficiencies

Mann-Whitney U

Modified Rodnan Skin Score

6 (2, 11.25)

3 (0, 8)

p = 0.007

Erythrocyte sedimentation rate

18 (8, 30)

10 (6, 22.5)

p = 0.027

HB (g/dl)

12.4 (11.4, 13.5)

13.6 (12.7, 14.325)

p<0.001

ACR, American College of Rheumatology; BMI, Body-Mass-Index; CK, creatine kinase; HB, Hemoglobin; MCP, metacarpophalangeal joint.

Normal serum levels of the micronutrients: zinc: 9 – 21µmol/l, selenium: 0.8 – 1.1µmol/l, prealbumin: 200 – 400mg/l, folic acid: > 4 µg/l, holotranscobalamin: > 35pmol/l. Measurement techniques: zinc – flame atomic absorption spectrometry (F-AAS); selenium –  graphite furnace atomic absorption spectrometry (GF-AAS); prealbumin –  immunonephelometry; holotranscobalamin – chemiluminescence microparticle immunoassay (CMIA); folic acid – chemiluminescence immunoassay.


Disclosure: J. Laeubli, None; R. Dobrota, Pfizer Inc, 2; B. Maurer, None; S. Jordan, None; B. Misselwitz, None; M. Fox, None; O. Distler, Actelion, Pfizer, Pharmacyclics, Ergonex, BMS, Sanofi-Aventis, United BioSource Corporation, Roche/Genentech, Medac, Biovitrium, Boehringer Ingelheim Pharma, Novartis, 4D Science, Active Biotec, Bayer-Schering, Sinoxa, Serodapharm, EpiPharm, Biogen, Inven, 5,Actelion, Pfizer, Pharmacyclics, Ergonex, BMS, Sanofi-Aventis, United BioSource Corporation, Roche/Genentech, Medac, Biovitrium, Boehringer Ingelheim Pharma, Novartis, 4D Science, Active Biotec, Bayer-Schering, Sinoxa, Serodapharm, EpiPharm, Biogen, Inven, 2.

To cite this abstract in AMA style:

Laeubli J, Dobrota R, Maurer B, Jordan S, Misselwitz B, Fox M, Distler O. Deficiency in Micronutrients Is a Frequent Burden in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/deficiency-in-micronutrients-is-a-frequent-burden-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deficiency-in-micronutrients-is-a-frequent-burden-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology